Zakariya Al-Muharrmi, Akbar Rafay, Abdullah Balkhair, Ali A Jabri
BACKGROUND: extended spectrum β-lactamase (ESBL) producing gram negative bacilli are becoming a growing problem worldwide with difficulties in designing a national formulary for empirical treatment of gram negative sepsis. OBJECTIVES: In this study, we investigated the in vitro activity of Carbapenems, Pipracillin-Tazobactam, Ciprofloxacin alone or in combination with aminoglycosides against ESBL-producing strains isolated from clinical samples. METHODS: Three hundred and one ESBL-producing Escherichia coli and K...
April 2008: Oman Medical Journal